SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-077652
Filing Date
2023-09-19
Accepted
2023-09-19 15:06:02
Documents
12
Period of Report
2023-09-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea185361-6k_scinaiimmu.htm 6-K 24326
2 FORM OF SECURITIES PURCHASE AGREEMENT ea185361ex1-1_scinaiimmu.htm EX-1.1 272385
3 FORM OF PRE-FUNDED WARRANT ea185361ex1-2_scinaiimmu.htm EX-1.2 115955
4 FORM OF WARRANT ea185361ex1-3_scinaiimmu.htm EX-1.3 101883
5 FORM OF PLACEMENT AGENT WARRANT ea185361ex1-4_scinaiimmu.htm EX-1.4 97384
6 PRESS RELEASE DATED SEPTEMBER 15, 2023 ea185361ex1-5_scinaiimmu.htm EX-1.5 13049
7 OPINION OF GOLDFARB GROSS SELIGMAN & CO ea185361ex5-1_scinaiimmu.htm EX-5.1 9810
8 OPINION OF LUCOSKY BROOKMAN, LLP ea185361ex5-2_scinaiimmu.htm EX-5.2 14002
9 GRAPHIC ex5-1_001.jpg GRAPHIC 11993
10 GRAPHIC ex5-1_002.jpg GRAPHIC 12725
11 GRAPHIC ex5-1_003.jpg GRAPHIC 9877
12 GRAPHIC ex5-2_001.jpg GRAPHIC 13925
  Complete submission text file 0001213900-23-077652.txt   717376
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 231263447
SIC: 2836 Biological Products, (No Diagnostic Substances)